Common Myths About Market Research
By DeltaMV Insights TeamReviewed by DeltaMV Academy EditorialUpdated 5 min read
Module 1 · 10 of 10Foundations of Healthcare Market ResearchAll articles
- What Is Market Research, Really? A Beginner’s Map of the Field
- Why Healthcare Market Research Is Different From Consumer Research
- A Short History: How Pharma & Healthcare Market Research Evolved
- Ethics, Compliance & Data Privacy in Healthcare Market Research
- Types of Healthcare Market Research Studies: Trackers, Ad Hoc, Syndicated & Custom
- How a Market Research Project Actually Runs
- Qualitative vs Quantitative Research
- Primary vs Secondary Research
- Who’s Who: The Healthcare Ecosystem
- Common Myths About Market Research
Market research carries a handful of persistent myths: that it’s just surveys, that bigger samples are always better, and that physicians’ stated intentions predict their behaviour. None of these hold up, and believing them leads directly to wasted budget, misread findings, or research that answers the wrong question entirely.
Key Takeaways
- “Market research” covers far more than surveys, and assuming otherwise narrows what gets commissioned.
- Sample size needs to match the method and the question, not just be maximised.
- Healthcare research shares its toolkit with consumer research, but stakeholders and regulation genuinely differ.
- Stated intent, especially from physicians, is a weak predictor of actual behaviour on its own.
- This article wraps up Module 1 by revisiting myths connected to earlier articles.
Myth 1: Market Research Is Just Surveys
- What people believe: Ask someone outside the field what market research looks like, and “survey” is almost always the first word that comes up.
- What’s actually true: Surveys are one tool among many. Qualitative interviews, trackers, secondary and desk research, and syndicated studies are all equally valid forms of market research, chosen based on the question being asked, as covered in the first article of this module.
- Why it matters: Teams that default to a survey for every question end up running quantitative studies to answer questions that needed qualitative depth, like understanding why physicians hesitate rather than how many do.
Myth 2: Bigger Samples Are Always Better
- What people believe: More respondents mean more trustworthy results, so bigger is always safer.
- What’s actually true: Sample size needs to match the method. A quantitative study genuinely needs a large enough sample for statistical confidence, but a qualitative study doesn’t get more useful by adding more interviews past the point where themes start repeating. It just gets more expensive.
- Why it matters: Oversized qualitative samples waste budget without adding insight, while undersized quantitative samples create a false sense of statistical confidence.
Myth 3: Healthcare Research Is Basically the Same as Consumer Research
- What people believe: If the methods are the same, the approach should transfer directly from consumer projects.
- What’s actually true: The methods genuinely overlap as the second article in this module covered, but healthcare research deals with multiple interdependent stakeholders, heavier regulation, and higher-stakes decisions that change how studies need to be designed and recruited.
- Why it matters: Treating a healthcare study exactly like a consumer project, same guide style, same recruitment approach, often produces guarded, low-quality responses from physicians in particular.
Myth 4: If Physicians Say They’ll Prescribe It, They Will
- What people believe: A physician’s stated intent in an interview or survey is a reliable predictor of what they’ll actually do.
- What’s actually true: Stated intent and actual prescribing behaviour frequently diverge, for reasons this Academy explores in depth starting in Module 2 on behavioural science and Module 3 on cognitive biases. Clinical judgment, habit, institutional pressure, and in-the-moment context all shape real behaviour in ways a single interview answer can’t fully capture.
- Why it matters: Treating stated intent as a forecast, rather than one input among several, leads to overconfident launch projections.
Myth 5: Secondary Research Is Outdated or Lower Quality
- What people believe: If data wasn’t collected specifically for your question, it’s probably stale or unreliable.
- What’s actually true: As the previous article in this module covered, secondary sources like government health statistics or published epidemiological studies can be more rigorously sampled than many primary studies could afford to be. Quality depends on the original source, not on whether it’s primary or secondary.
- Why it matters: Skipping secondary research by default sometimes means paying to rediscover something that was already published.
Myth 6: Research Findings Speak for Themselves
- What people believe: Once the data is in, the answer is obvious. Just report the numbers or the quotes.
- What’s actually true: Raw findings still need interpretation, connecting what was found back to the actual business decision stated in the brief, covered in the article on how a project runs. Two people can look at the same data and reach different recommendations depending on how well they understood the original decision.
- Why it matters: Research that isn’t translated into a clear recommendation tied to the original decision often gets read, nodded at, and then ignored.
The Cheat Sheet
Six myths, one underlying lesson: market research works best when the method, sample, and interpretation all match the actual question being asked, not when you default to the biggest, fastest, or most familiar option available.
A DeltaMV Perspective
A recurring pattern shows up across projects. A client arrives already convinced of a finding, usually something like “physicians will definitely switch once they see the data,” based on a handful of informal conversations or an earlier survey’s stated intent. The research is then commissioned less to test that belief than to confirm it. On more than one occasion, a properly designed study including a few qualitative interviews probing the gap between stated intent and real-world behaviour has surfaced a more complicated picture. Physicians genuinely intended to switch but rarely acted on it due to workflow friction or institutional habit. Those findings are harder to deliver than a simple confirmation, but they’re also far more useful, because they point at an actual barrier a team can address instead of a number that looks reassuring but doesn’t hold up once a campaign launches.
Composite/anonymized example; not a specific client or study.
FAQ
Why do these myths persist even among experienced marketers?
Many of them come from habits formed in consumer research or general business contexts where the stakes, regulation, and stakeholder complexity are lower. The myths aren’t unreasonable assumptions in general. They just don’t hold up as well in healthcare specifically.
Is it ever okay to rely on a small qualitative sample for a major decision?
Yes, if the question is about understanding reasoning or language rather than sizing a behaviour. The key is matching the method to the question, not the size of the decision to the size of the sample.
How can a team avoid falling for these myths?
Going back to the brief covered in the article on how a project runs a project runs and being explicit about what decision the research needs to inform usually exposes which myths might be creeping into the plan.
Does this mean quantitative research is less valuable than qualitative?
No, neither is inherently more valuable. Each answers different questions, and the myths above apply equally to both methods when they’re used for the wrong reason or treated uncritically.
The Bottom Line
Most market research myths share a common root: defaulting to the familiar, more surveys, bigger samples, the same approach as consumer research, instead of matching the method to the actual question. Module 1 has covered the fundamentals needed to make those matches deliberately. The rest of this Academy builds on that foundation.